Tissue engineering entails the in vitro development of bioartificial tissues as well as the in vivo manipulation of cell growth and function using cells isolated from donor tissue and biocompatible scaffold materials. To facilitate effective cell adhesion, migration, and deposition of endogenous extracellular matrix components by the cells, biomaterials for tissue engineering must have regulated surface chemistry, porosity, and biodegradability. To create a large cell mass that can perform certain differentiated roles required for the tissue build, strategies to switch cells between growth and differentiation, which are mutually exclusive, are applied. TE has a lot of potential. The social impact of TE will be extraordinary. It bears the promise of a long-term improvement in human life quality, as well as a decrease in the societal and economic costs of healthcare and life expectancy. It has the ability to provide early diagnosis of pathological disorders, lower the harshness of treatment, and improve the patient's clinical outcome. It could lead to the discovery of fresh methods for promoting health and lifespan.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy